Changeflow GovPing Pharma & Drug Safety Pyrimidine Compounds for Cancer Prevention Trea...
Routine Notice Added Draft

Pyrimidine Compounds for Cancer Prevention Treatment

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO published patent application US20260092051A1 for pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers. Inventors include In Hwan Bae, Ji Sook Kim, Jae Yul Choi, and others. The application (No. 19203828) was filed on May 9, 2025, and published on April 2, 2026. This is an informational publication with no compliance requirements.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO published a patent application (US20260092051A1) for pyrimidine compounds represented by Formula 1, methods of preparing the compounds, and their pharmaceutical use for cancer prevention or treatment. The application includes CPC classifications C07D 403/14, A61P 35/02, A61K 31/4025, and A61K 31/506, indicating chemical compounds with therapeutic applications.

Patent applications are informational publications and do not impose compliance obligations on regulated entities. Compliance teams need not take action unless monitoring for potential future patent landscape developments or competitive intelligence related to oncology drug candidates.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME

Application US20260092051A1 Kind: A1 Apr 02, 2026

Inventors

In Hwan BAE, Ji Sook KIM, Jae Yul CHOI, Seok Jong KANG, Young Gil AHN, Kwee Hyun SUH

Abstract

Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.

CPC Classifications

C07D 403/14 A61P 35/02 A61K 31/4025 A61K 31/506

Filing Date

2025-05-09

Application No.

19203828

View original document →

Named provisions

Abstract Inventors CPC Classifications

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260092051A1
Docket
19203828

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!